Hyperthyroidism
Propylthiouracil is preferred therapy for pregnant women with thyroid disease
Published in Women's Health Weekly, April 1st, 2004
According to a study from France, "first cause of hyperthyroidism among women of childbearing age, Graves' disease raises the risk of maternal and fetal complications, including eclampsia, cardiac failure, abortion, prematurity, fetal death, all of which can be avoided if maternal hyperthyroidism is closely controlled."
"The risk of transplacental hyperthyroidism has been shown to correlate to the titer of anti-thyroid stimulating hormone (TSH) receptor antibodies and has to be evaluated not only in women treated for Graves' disease during pregnancy, but also in women who...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Black women in U.S. more likely to have delayed diagnosis, treatment - Osteoporosis
Risedronate reduces nonvertebral fracture risk within 6 months of initiation - Abortion
Ultrasounds are advised for all women who request pregnancy termination - Endocrinology
Lipid profiles are significantly related to bone mass in women and men - Obstetrics
The accuracy of reported preterm birth rates is questionable - Osteoporosis
When combined, alendronate and HRT have no added benefit for gaining bone mass - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
